These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8228370)
21. Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model. Szilágyi J; Földi R; Gesztelyi R; Bayegan S; Kardos G; Juhász B; Majoros L Chemotherapy; 2012; 58(2):159-64. PubMed ID: 22626860 [TBL] [Abstract][Full Text] [Related]
22. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Wingard JR; Merz WG; Rinaldi MG; Miller CB; Karp JE; Saral R Antimicrob Agents Chemother; 1993 Sep; 37(9):1847-9. PubMed ID: 8239594 [TBL] [Abstract][Full Text] [Related]
23. Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B. Lopez-Berestein G; Hopfer RL; Mehta R; Mehta K; Hersh EM; Juliano RL Antimicrob Agents Chemother; 1984 Mar; 25(3):366-7. PubMed ID: 6721469 [TBL] [Abstract][Full Text] [Related]
24. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088 [TBL] [Abstract][Full Text] [Related]
26. Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice. van Etten EW; van den Heuvel-de Groot C; Bakker-Woudenberg IA J Antimicrob Chemother; 1993 Nov; 32(5):723-39. PubMed ID: 8125837 [TBL] [Abstract][Full Text] [Related]
27. Treatment of systemic candidiasis in a neutropenic murine model using immunoglobulin G bearing liposomal amphotericin B. Belay T; Hospenthal DR; Rogers AL; Patterson MJ Mycopathologia; 1993 Jul; 123(1):9-17. PubMed ID: 8247096 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of triazoles in a murine disseminated infection by Candida krusei. Mariné M; Pastor FJ; Serena C; Guarro J Antimicrob Agents Chemother; 2009 Aug; 53(8):3585-8. PubMed ID: 19470509 [TBL] [Abstract][Full Text] [Related]
29. Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. Sugar AM; Hitchcock CA; Troke PF; Picard M Antimicrob Agents Chemother; 1995 Mar; 39(3):598-601. PubMed ID: 7793858 [TBL] [Abstract][Full Text] [Related]
30. Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile. Scorzoni L; de Lucas MP; Mesa-Arango AC; Fusco-Almeida AM; Lozano E; Cuenca-Estrella M; Mendes-Giannini MJ; Zaragoza O PLoS One; 2013; 8(3):e60047. PubMed ID: 23555877 [TBL] [Abstract][Full Text] [Related]
31. Fluconazole resistance of Candida krusei. Manso E; Montillo M; Discepoli G; Leoni P Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057 [TBL] [Abstract][Full Text] [Related]
32. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648 [TBL] [Abstract][Full Text] [Related]
33. Severe candidal infections in neutropenic patients. Swerdloff JN; Filler SG; Edwards JE Clin Infect Dis; 1993 Nov; 17 Suppl 2():S457-67. PubMed ID: 8274612 [TBL] [Abstract][Full Text] [Related]
34. Successful treatment of candidal osteomyelitis with fluconazole following failure with liposomal amphotericin B. Turner DL; Johnson SA; Rule SA J Infect; 1999 Jan; 38(1):51-3. PubMed ID: 10090510 [TBL] [Abstract][Full Text] [Related]
35. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae. Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922 [TBL] [Abstract][Full Text] [Related]
36. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. Lopez-Berestein G; Hopfer RL; Mehta R; Mehta K; Hersh EM; Juliano RL J Infect Dis; 1984 Aug; 150(2):278-83. PubMed ID: 6470530 [TBL] [Abstract][Full Text] [Related]
37. Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. Viviani MA; Tortorano AM; Malaspina C; Colledan M; Paone G; Rossi G; Bordone G; Pagano A Eur J Epidemiol; 1992 May; 8(3):433-6. PubMed ID: 1397207 [TBL] [Abstract][Full Text] [Related]
38. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients]. Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669 [TBL] [Abstract][Full Text] [Related]
39. Antifungal activity of D0870 against murine infections and its mechanism of action. Yamada H; Tsuda T; Watanabe T; Kusakabe S; Mochizuki H Chemotherapy; 1998; 44(2):112-20. PubMed ID: 9551242 [TBL] [Abstract][Full Text] [Related]
40. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. Lopez-Berestein G; Mehta R; Hopfer RL; Mills K; Kasi L; Mehta K; Fainstein V; Luna M; Hersh EM; Juliano R J Infect Dis; 1983 May; 147(5):939-45. PubMed ID: 6842027 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]